News Focus
News Focus
icon url

Pazzo1212

06/19/21 1:05 PM

#315808 RE: Investor2014 #315806

Biotech is a crapshoot for sure. Let’s hope we have the needle in the haystack….
icon url

boi568

06/19/21 1:06 PM

#315810 RE: Investor2014 #315806

Had Orphazyme worked through the underlying science to the degree that Anavex has, and did they have supporting results in other indications? Or was it the usual one trial, one indication shot in the dark?
icon url

powerwalker

06/19/21 3:35 PM

#315848 RE: Investor2014 #315806

Bad week for the Danes, Investor. Sorry about ORPH and Euro 2020.

I agree with you that the ORPH looked good enough to get a similar OK as Biogen and adu*, at a minimum ... given the lack of any help currently.

Made $$ last week on WSB crowd run-up and broke even this week on it.

This is a good example of what looks good to investors might not be that way when it is the FDA doing the looking!